Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1998-03-27
1999-05-11
Lee, Howard C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536112, A61K31/715
Patent
active
059028009
ABSTRACT:
This disclosure describes pharmaceutical compositions and a method for treatment of joint inflammation and pain bought about by e.g. arthritis, physical trauma, bacterial or viral infection. In one embodiment, the method comprises administration of a bimodal molecular weight dextran formulation comprising 0.2 to 32% w/v of a dextran fraction with average molecular weight between 30,000 and 110,000 daltons and 0.2 to 6% dextran with an average molecular weight between 500 and 3,000 daltons, into the joint of a warm blooded animal.
REFERENCES:
Barghouthi et al., "Inhibition by Dextran of Pseudomonas aeruginosa Adherence to Epithelial Cells", Am. J. Respir. Crit. Care Med., vol. 154(6): 1788-1793, 1996.
Timsit et al. "Proprietes anti-inflammatoires et anticomplementaires de dextrans de poids moleculaires varies", C.R. Seances Soc. Biol. Fil., vol. 165(2): 268-273, 1971.
de Belder, Anthony N. "Medical Applications of Dextran and Its Derivatives" from Polysaccharides in Medicinal Chemistry, ed. by Severian Dumitriu, publ. by Marcel Dekker, Inc., pp. 505-523, 1996.
Albuquerque, M., et al., "Articular Lymphoscintigraphy in Human Knees Using Radiolabeled Dextran," Lymphology 23 (1990), pp. 215-218.
Arfors, K., et al., "Pharmacological Characteristics of Artificial Colloids," Bailliere's Clin. Anaesthesiol., vol. 11, No. 1, 1997, pp. 15-47.
Green, J., "Macrodex and Arthritic Joints," J. Orthopaedic Med., 19 (1) Apr. 1997, 27-28.
Grennan, D.M., et al., "The Effects of Prostaglandin E.sub.1, Bradykinin and Histamine on Canine Synovial Vascular Permeability," Br. J. Pharmac., 1977, 60, pp. 251-254.
Jurvelin, J.S. et al., "Effects of Different Irrigation Liquids and Times on Articular Cartilage: An Experimental, Biomechanical Study," Arthroscopy: J. Arthroscop. & Related Surgery, 10(6), 1994, pp. 667-672.
Menger, M.D., "Microcirculatory Disturbances Secondary to Ischemia-Reperfusion," Transplant. Proceed., vol. 27, No. 5 (Oct. 1995), pp. 2863-2865.
Hedin, H., et al., "Incidence, Pathomechanism and Prevention of Dextran-Induced Anaphylactoid/Anaphylactic Reactions in Man," Develop. Biol. Standard., 48, (1980) pp. 179-189.
Moreno, J.L., et al., "Articular Irrigation in Arthroscopic Procedures," Int. Ortopaedics (SICOT), 1986, 10, pp. 101-104 (w/English summary).
Smith, M.M., "The Effects of Some Polysulphated Polysaccharides on Hyaluronate (HA) Synthesis by Human Synovial Fibroblasts," Agents & Actions Supplements, vol. 18, 1986, pp. 55-62.
Buckley Peter B.
Green June Ha
Glenpharma
Lee Howard C.
LandOfFree
Dextran formulations and method for treatment of inflammatory jo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dextran formulations and method for treatment of inflammatory jo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dextran formulations and method for treatment of inflammatory jo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-245723